Literature DB >> 8465868

Cigarette smoking: implications for psychiatric illness.

A H Glassman1.   

Abstract

Psychiatry has been essentially uninterested in cigarette smoking and nicotine. However, it is the view of this author that both cigarette smoking and smoking cessation are highly relevant to the clinical psychiatrist in the care of patients and that they are potentially a source of important insights into psychopathology. To support that view, the author reviews the evidence that both major depression and depressive symptoms are associated with a high rate of cigarette smoking and that lifetime history of major depression has an adverse impact on smoking cessation. He also reviews the data available on the influence of cigarette smoking cessation on the course of major depression, the relationship between cigarette smoking and other psychiatric diagnoses, particularly schizophrenia, and the neuropharmacology that might underlie these associations. Finally, the implications of these relationships for psychiatry are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8465868     DOI: 10.1176/ajp.150.4.546

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  110 in total

1.  Associations of family environment and individual factors with tobacco, alcohol, and illicit drug use in adolescents.

Authors:  B Challier; N Chau; R Prédine; M Choquet; B Legras
Journal:  Eur J Epidemiol       Date:  2000-01       Impact factor: 8.082

2.  Cigarette smoking and mood disorders in U.S. adolescents: sex-specific associations with symptoms, diagnoses, impairment and health services use.

Authors:  Amanda Richardson; Jian-Ping He; Laurel Curry; Kathleen Merikangas
Journal:  J Psychosom Res       Date:  2012-02-18       Impact factor: 3.006

3.  Genetic interaction between alpha4 and beta2 subunits of high affinity nicotinic receptor: analysis in schizophrenia.

Authors:  Vincenzo De Luca; Sophocles Voineskos; Greg Wong; James L Kennedy
Journal:  Exp Brain Res       Date:  2006-04-25       Impact factor: 1.972

Review 4.  Genetics of smoking and depression.

Authors:  Ming T Tsuang; Tracee Francis; Kyle Minor; Alison Thomas; William S Stone
Journal:  Hum Genet       Date:  2012-04-17       Impact factor: 4.132

5.  The added costs of depression to medical care.

Authors:  K Franco; M Tamburino; N Campbell; J Zrull; C Evans; D Bronson
Journal:  Pharmacoeconomics       Date:  1995-04       Impact factor: 4.981

6.  Relationship between tobacco consumption and health-related quality of life in adults living in a large metropolitan area.

Authors:  Javier de Miguel Díez; Maria Mercedes Esteban y Peña; Luis Puente Maestu; Valentín Hernández Barrera; Pilar Carrasco Garrido; Luis A Alvarez-Sala Walther; Rodrigo Jiménez García
Journal:  Lung       Date:  2010-08-19       Impact factor: 2.584

Review 7.  Nicotinic modulation of innate immune pathways via α7 nicotinic acetylcholine receptor.

Authors:  Wen-Yan Cui; Ming D Li
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

8.  A comprehensive model for mental health tobacco recovery in new jersey.

Authors:  Jill M Williams; Mia Hanos Zimmermann; Marc L Steinberg; Kunal K Gandhi; Cris Delnevo; Michael B Steinberg; Jonathan Foulds
Journal:  Adm Policy Ment Health       Date:  2011-09

Review 9.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

10.  Bupropion and cognitive-behavioral treatment for depression in smoking cessation.

Authors:  Richard A Brown; Raymond Niaura; Elizabeth E Lloyd-Richardson; David R Strong; Christopher W Kahler; Ana M Abrantes; David Abrams; Ivan W Miller
Journal:  Nicotine Tob Res       Date:  2007-07       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.